Celldex (TCE2) Stock Statistics & Valuation Metrics
Total Valuation
Celldex has a market cap or net worth of EUR 2.12B. The enterprise value is EUR 2.19B.
- Market Cap
- EUR 2.12B
- Enterprise Value
- EUR 2.19B
Share Statistics
Celldex has 78,529,530 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 78,529,530
- Owned by Insiders
- 0.30%
- Owned by Institutions
- 47.07%
Financial Efficiency
Celldex’s return on equity (ROE) is -0.49 and return on invested capital (ROIC) is -53.87%.
- Return on Equity (ROE)
- -0.49
- Return on Assets (ROA)
- -0.44
- Return on Invested Capital (ROIC)
- -53.87%
- Return on Capital Employed (ROCE)
- -0.54
- Revenue Per Employee
- 7,575.758
- Profits Per Employee
- -1.31M
- Employee Count
- 198
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Celldex is -6.90. Celldex’s PEG ratio is 0.20.
- PE Ratio
- -6.90
- PS Ratio
- 21104.80
- PB Ratio
- 3.28
- Price to FCF
- -9.77
- Price to Operating Cash Flow
- -9.95
- PEG Ratio
- 0.20
Income Statement
In the last 12 months, Celldex had revenue of 1.50M and earned -258.80M in profits. Earnings per share was -3.90.
- Revenue
- 1.50M
- Gross Profit
- 1.50M
- Operating Income
- -287.40M
- Pretax Income
- -258.80M
- Net Income
- -258.80M
- EBITDA
- -255.42M
- Earnings Per Share (EPS)
- -3.90
Cash Flow
In the last 12 months, operating cash flow was -235.57M and capital expenditures -6.25M, giving a free cash flow of -241.82M billion.
- Operating Cash Flow
- -235.57M
- Free Cash Flow
- -241.82M
- Free Cash Flow per Share
- -3.11
Dividends & Yields
Celldex pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -10.55%
- Earnings Yield
- -13.23%
Stock Price Statistics
- Beta
- 0.74
- 52-Week Price Change
- 18.92%
- 50-Day Moving Average
- 29.65
- 200-Day Moving Average
- 27.99
- Relative Strength Index (RSI)
- 46.09
- Average Volume (3m)
- 171
Important Dates
Celldex upcoming earnings date is Nov 11, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 06, 2026
- Next Earnings Date
- Nov 11, 2026
- Ex-Dividend Date
- ―
Financial Position
Celldex as a current ratio of 10.49, with Debt / Equity ratio of 0.44%
- Current Ratio
- 10.49
- Quick Ratio
- 10.49
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.10
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Celldex has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Celldex EV to EBITDA ratio is -7.57, with an EV/FCF ratio of -9.30.
- EV to Sales
- 20079.83
- EV to EBITDA
- -7.57
- EV to Free Cash Flow
- -9.30
- EV to Operating Cash Flow
- -9.55
Balance Sheet
Celldex has EUR 717.59M in cash and marketable securities with EUR 4.90M in debt, giving a net cash position of EUR 712.68M billion.
- Cash & Marketable Securities
- EUR 717.59M
- Total Debt
- EUR 4.90M
- Net Cash
- EUR 712.68M
- Net Cash Per Share
- EUR 9.08
- Tangible Book Value Per Share
- EUR 8.83
Margins
Gross margin is -56850.89%, with operating margin of -290948.21%, and net profit margin of -268385.71%.
- Gross Margin
- -56850.89%
- Operating Margin
- -290948.21%
- Pretax Margin
- -268385.71%
- Net Profit Margin
- -268385.71%
- EBITDA Margin
- -265353.57%
- EBIT Margin
- -268385.71%
Analyst Forecast
The average price target for Celldex is EUR 59.23, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 59.23
- Price Target Upside
- 124.35% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 12
- Revenue Growth Forecast
- -97.44%
- EPS Growth Forecast
- -35.11%
Scores
- Smart Score
- 7
- AI Score
- ―
